Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation

Cardiovascular Research

Volumn 97, Issue 1, 2013, Pages 33-43

  Yang, Changjun ^a   Talukder, M A Hassan ^a   Varadharaj, Saradhadevi ^a   Velayutham, Murugesan ^a   Zweier, Jay L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Endothelial nitric oxide synthase structure; Protein phosphorylation; Reactive oxygen species; Signalling pathways

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; PROTEIN KINASE B; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MODIFICATION; FLUORESCENCE MICROSCOPY; HEART MUSCLE CELL; IMMUNOHISTOLOGY; IMMUNOPRECIPITATION; INFARCTION; ISCHEMIC PRECONDITIONING; MALE; MASS SPECTROMETRY; MUSCLE CONTRACTILITY; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPIN TRAPPING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; IMMUNOPRECIPITATION; ISCHEMIC PRECONDITIONING; MALE; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PERFUSION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84871758700     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs287     Document Type: Article

References (44)

1. Downey JM, Davis AM, Cohen MV. Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007;12:181-188. (Pubitemid 350176691)
2. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci 2002;962:18-41. (Pubitemid 34592297)
3. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 1997;273:H2931-H2936.
4. Bolli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 1997;81:1094-1107. (Pubitemid 27514960)
5. Talukder MA, Yang F, Shimokawa H, Zweier JL. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. Am J Physiol Heart Circ Physiol 2010;299:H437-H445.
6. Muscari C, Bonafe F, Gamberini C, Giordano E, Tantini B, Fattori M et al. Early preconditioning prevents the loss of endothelial nitric oxide synthase and enhances its activity in the ischemic/reperfused rat heart. Life Sci 2004;74:1127-1137. (Pubitemid 37542419)
7. Bell RM, Yellon DM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res 2001;52:274-280. (Pubitemid 33000404)
8. Weselcouch EO, Baird AJ, Sleph P, Grover GJ. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol 1995; 268:H242-H249.
9. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 2000;32:1159-1167.
10. Elrod JW, Greer JJ, Bryan NS, Langston W, Szot JF, Gebregzlabher H et al. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocar-dial ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 2006;26:1517-1523. (Pubitemid 44288977)
11. Frantz S, Adamek A, Fraccarollo D, Tillmanns J, Widder JD, Dienesch C et al. The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol 2009;104:773-779.
12. Szelid Z, Pokreisz P, Liu X, Vermeersch P, Marsboom G, Gillijns H et al. Cardioselec-tive nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury. Basic Res Cardiol 2010;105:169-179.
13. Bellis A, Castaldo D, Trimarco V, Monti MG, Chivasso P, Sadoshima J et al. Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning. Arterioscler Thromb Vasc Biol 2009;29:1207-1212.
14. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Agullo L, Pina P, Soler-Soler J. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res 2004;64:105-114. (Pubitemid 39208927)
15. Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sjoquist PO et al. Adipo-nectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res 2008;78:116-122. (Pubitemid 351430967)
16. Giraldez RR, Panda A, Zweier JL. Endothelial dysfunction does not require loss of endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2000;278: H2020-H2027. (Pubitemid 30439216)
17. Wei G, Dawson VL, Zweier JL. Role of neuronal and endothelial nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochim Biophys Acta 1999;1455:23-34. (Pubitemid 29397486)
18. Knudsen GM, Nishida CR, Mooney SD, Ortiz de Montellano PR. Nitric-oxide syn-thase (NOS) reductase domain models suggest a new control element in endothelial NOS that attenuates calmodulin-dependent activity. J Biol Chem 2003;278:31814-31824. (Pubitemid 37048363)
19. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced cal-modulin dissociation may explain "calcium-independent" eNOS activation by phos-phorylation. J Biol Chem 2000;275:6123-6128. (Pubitemid 30129896)
20. Wei G, Zweier JL. Endothelial nitric oxide synthase is essential for actute ischemic preconditioning. FASEB J 2001;15:A465.
21. Zweier JL, Yang F, Nishijima Y, Chen CA, Yang C, Varadharaj S et al. Novel rapid-multiple-short-cycle preconditioning stimuli induces robust cardioprotective signaling mechanisms and protects the heart against in vivo ischemia reperfusion injury: an effective approach with clinical justification. FASEB J 2012;26:1136.
22. Kelly RA, Balligand JL, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-380. (Pubitemid 26276897)
23. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1995;1:804-809.
24. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 1995;270:304-307.
25. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 1999;100:2260-2266.
26. Genade S, Genis A, Ytrehus K, Huisamen B, Lochner A. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 2008;45:449-458.
27. Luo Z, Fujio Y, Kureishi Y, Rudic RD, Daumerie G, Fulton D et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest 2000;106:493-499. (Pubitemid 30666382)
28. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-460. (Pubitemid 38210151)
29. O'Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J Clin Invest 2005;115:2059-2064. (Pubitemid 41134142)
30. Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S et al. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation 2004;110:51-57. (Pubitemid 38880133)
31. Sadat U. Signaling pathways of cardioprotective ischemic preconditioning. Int J Surg 2009;7:490-498.
32. Li XD, Yang YJ, Geng YJ, Jin C, Hu FH, Zhao JL et al. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. Am J Physiol Heart Circ Physiol 2010;299:H1255-H1261.
33. Robinet A, Hoizey G, Millart H. PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. Cardiovasc Res 2005; 66:530-542. (Pubitemid 40725765)
34. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996;271:29223-29230. (Pubitemid 26382634)
35. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G et al. Myocar-dial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA 2007;104:15081-15086. (Pubitemid 47619596)
36. Zweier JL, Kuppusamy P, Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 1988;85:4046-4050.
37. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998;273:25804-25808.
38. Chen CA, Druhan LJ, Varadharaj S, Chen YR, Zweier JL. Phosphorylation of endothe-lial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem 2008;283:27038-27047.
39. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 2007;42:271-279. (Pubitemid 46135596)
40. Greif DM, Kou R, Michel T. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: evidence for crosstalk between phosphorylation sites. Biochemistry 2002;41:15845-15853. (Pubitemid 36062490)
41. Michell BJ, Chen Z, Tiganis T, Stapleton D, Katsis F, Power DA et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001;276:17625-17628.
42. Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J et al. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 2002;277:3388-3396. (Pubitemid 34953207)
43. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999;399:601-605.
44. Kukreja RC, Xi L. eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?. J Mol Cell Cardiol 2007;42:280-282. (Pubitemid 46135602)